Bromocriptine mesylate
- Strength
- 2.5 mg/1
- Form
- Tablet
- Class
- Ergot Derivative
Padagis US LLC
Not stocked by us — reference only
Listed by Zydus Lifesciences Limited
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Ergot Derivative |
| Approval route | ANDA — approved generic |
| NDC code | 65841-654 |
| FDA application | ANDA078899 |
| RxNorm concept | 197412 |
| Package sizes listed | 2 |
| Marketed since | January 2009 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Padagis US LLC
Not stocked by us — reference only
REMEDYREPACK INC.
Not stocked by us — reference only
ANI Pharmaceuticals, Inc.
Not stocked by us — reference only
American Health Packaging
Not stocked by us — reference only
ANI Pharmaceuticals, Inc.
Not stocked by us — reference only
Zydus Pharmaceuticals USA Inc.
Not stocked by us — reference only
Sandoz Inc
Not stocked by us — reference only
Mylan Pharmaceuticals Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.